Cover Image
Market Research Report

Molecular Diagnostics Market by Application (Infectious Disease (Hepatitis, HIV), Oncology, Genetic Testing), Technology (PCR, DNA Sequencing & NGS), End User (Hospital/Academic Laboratory), Product & Service (Reagent, Software): Global Forecast to 2023

Published by MarketsandMarkets Product code 253279
Published Content info 242 Pages
Immediate Delivery Available
Price
Back to Top
Molecular Diagnostics Market by Application (Infectious Disease (Hepatitis, HIV), Oncology, Genetic Testing), Technology (PCR, DNA Sequencing & NGS), End User (Hospital/Academic Laboratory), Product & Service (Reagent, Software): Global Forecast to 2023
Published: May 24, 2018 Content info: 242 Pages
Description

"The global molecular diagnostics market is projected to grow at a CAGR of 8.4%."

The global molecular diagnostics market is expected to reach USD 11.54 billion by 2023 from USD 7.71 billion in 2018, at a CAGR of 8.4%. Growth in this market can primarily be attributed to the high prevalence of infectious diseases and various types of cancers, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market, and advancements in molecular techniques. However, complex regulatory frameworks delaying the approval of new molecular diagnostic tests are expected to restrain the growth of this market during the forecast period.

"The reagents & kits segment to dominate the molecular diagnostics market, by product & service in 2018."

Based on product and service, the molecular diagnostics market is segmented into reagents and kits, instruments, and services and software. The reagents and kits segment is expected to account for the largest share of the global molecular diagnostics market in 2018. The large share of this segment can be attributed to the availability of a wide range of reagents and kits, rising use of reagents and kits in different therapeutic areas (such as infectious diseases and oncology), increase in basic research and commercial applications, and easy accessibility to a wide range of reagents.

"The market in the Asia Pacific region is projected to register the highest CAGR during the forecast period."

Asia Pacific is expected to register the highest CAGR in the global molecular diagnostics market during the forecast period. Market growth in the Asia Pacific is attributed to growing GDPs and a significant rise in disposable income levels, increased healthcare spending by a larger population base, modernization of healthcare infrastructure, and rising penetration of cutting-edge clinical laboratory technologies (especially in rural areas).

Break-up profile of primaries::

  • By Company Type - Tier I: 40%, Tier II: 30%, and Tier III: 30%
  • By Designation - C-level: 27%, D-level: 18%, and Others: 55%
  • By Region - North America: 50%, Europe: 20%, Asia Pacific: 20%, and the RoW: 10%

The key players operating in the global molecular diagnostics market are Roche (Switzerland), Hologic (US), QIAGEN (Netherlands), Abbott (US), and Danaher (US).

Research Coverage:

In this report, the molecular diagnostics market is segmented on the basis of product & service, application, technology, end user, and region. The study tracks and analyzes competitive developments such as product launches & approvals, acquisitions, collaborations, agreements, partnerships, and expansions, and core competencies in the molecular diagnostics market.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on portfolios offered by the top players in the global molecular diagnostics market. The report analyzes the market, by product & service, application, technology, end user, and region
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the global molecular diagnostics market
  • Market Development: Comprehensive information about lucrative emerging markets-the report analyzes the markets for molecular diagnostic products across regions
  • Market Diversification: Exhaustive information about new products, untapped regions, and recent developments in the global molecular diagnostics market
  • Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of the key players in the global molecular diagnostics market
Table of Contents
Product Code: MD 2521

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
    • 1.2.1. MARKETS COVERED
    • 1.2.2. YEARS CONSIDERED FOR THE STUDY
  • 1.3. CURRENCY
  • 1.4. LIMITATIONS
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. PRIMARY DATA
    • 2.1.1. KEY DATA FROM PRIMARY SOURCES
    • 2.1.2. KEY INDUSTRY INSIGHTS
  • 2.2. SECONDARY DATA
    • 2.2.1. KEY DATA FROM SECONDARY SOURCES
  • 2.3. MARKET SIZE ESTIMATION
  • 2.4. MARKET BREAKDOWN AND DATA TRIANGULATION
    • 2.4.1. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. MOLECULAR DIAGNOSTICS: MARKET OVERVIEW
  • 4.2. MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY AND REGION, 2018
  • 4.3. MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT AND SERVICE, 2018 VS. 2023(USD BILLION)
  • 4.4. MOLECULAR DIAGNOSTICS MARKET, BY END USER

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. High prevalence of infectious diseases and various types of cancers
      • 5.2.1.2. Increasing awareness and acceptance of personalized medicine and companion diagnostics
      • 5.2.1.3. Growth in the biomarker identification market and advancements in molecular techniques
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Complex regulatory frameworks delaying the approval of new molecular diagnostic tests
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Advances in genomics and proteomics
      • 5.2.3.2. Growth opportunities in emerging markets
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Dearth of trained professionals limiting the appropriate use of new molecular diagnostic technologies

6. MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE

  • 6.1. INTRODUCTION
  • 6.2. REAGENTS & KITS
  • 6.3. INSTRUMENTS
  • 6.4. SERVICES & SOFTWARE

7. MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY

  • 7.1. INTRODUCTION
  • 7.2. POLYMERASE CHAIN REACTION (PCR)
  • 7.3. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT)
  • 7.4. DNA SEQUENCING & NEXT-GENERATION SEQUENCING (NGS)
  • 7.5. IN SITU HYBRIDIZATION
  • 7.6. DNA MICROARRAY
  • 7.7. OTHER TECHNOLOGIES

8. MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. INFECTIOUS DISEASES
    • 8.2.1. HEPATITIS
    • 8.2.2. HIV
    • 8.2.3. CT/NG
    • 8.2.4. HAIS
    • 8.2.5. HPV
    • 8.2.6. TUBERCULOSIS
    • 8.2.7. INFLUENZA
    • 8.2.8. OTHER INFECTIOUS DISEASES
  • 8.3. ONCOLOGY
    • 8.3.1. BREAST CANCER
    • 8.3.2. COLORECTAL CANCER
    • 8.3.3. LUNG CANCER
    • 8.3.4. PROSTATE CANCER
    • 8.3.5. OTHER CANCERS
  • 8.4. GENETIC TESTS
  • 8.5. OTHER APPLICATIONS

9. MOLECULAR DIAGNOSTICS MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. HOSPITAL & ACADEMIC LABORATORIES
  • 9.3. REFERENCE LABORATORIES
  • 9.4. OTHER END USERS

10. MOLECULAR DIAGNOSTICS MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. US
    • 10.2.2. CANADA
  • 10.3. EUROPE
    • 10.3.1. GERMANY
    • 10.3.2. FRANCE
    • 10.3.3. ITALY
    • 10.3.4. SPAIN
    • 10.3.5. UK
    • 10.3.6. REST OF EUROPE
  • 10.4. ASIA PACIFIC
    • 10.4.1. JAPAN
    • 10.4.2. CHINA
    • 10.4.3. AUSTRALIA
    • 10.4.4. INDIA
    • 10.4.5. ROAPAC
  • 10.5. REST OF THE WORLD
    • 10.5.1. LATIN AMERICA
      • 10.5.1.1. Brazil
      • 10.5.1.2. Mexico
      • 10.5.1.3. Rest of Latin America
    • 10.5.2. MIDDLE EAST & AFRICA

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. MARKET SHARE ANALYSIS
  • 11.3. MOLECULAR DIAGNOSTICS MARKET COMPETITIVE SHARE ANALYSIS, BY APPLICATION
    • 11.3.1. MARKET SHARE ANALYSIS FOR INFECTIOUS DISEASE APPLICATIONS
    • 11.3.2. MOLECULAR DIAGNOSTICS MARKET SHARE ANALYSIS, BY TECHNOLOGY
      • 11.3.2.1. POLYMERASE CHAIN REACTION (PCR)
      • 11.3.2.2. DNA SEQUENCING AND NGS
      • 11.3.2.3. IN SITU HYBRIDIZATION (ISH)
  • 11.4. COMPETITIVE SITUATION AND TRENDS
    • 11.4.1. NEW PRODUCT LAUNCHES AND APPROVALS, 2016-2018
    • 11.4.2. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2016-2018
    • 11.4.3. ACQUISITIONS AND MERGERS
    • 11.4.4. EXPANSIONS

12. COMPANY PROFILES (Business Overview, Products Offered, Services Offered, Recent Developments, MnM View)*

  • 12.1. ABBOTT LABORATORIES
  • 12.2. AGILENT TECHNOLOGIES
  • 12.3. BECTON, DICKINSON AND COMPANY
  • 12.4. BIOMERIEUX SA
  • 12.5. DANAHER CORPORATION
  • 12.6. DIASORIN
  • 12.7. GRIFOLS
  • 12.8. HOLOGIC
  • 12.9. ILLUMINA
  • 12.10. QIAGEN
  • 12.11. ROCHE DIAGNOSTICS
  • 12.12. SIEMENS AG
  • 12.13. THERMO FISHER SCIENTIFIC

*Details might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. DISCUSSION GUIDE
  • 13.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.4. AVAILABLE CUSTOMIZATIONS
  • 13.5. RELATED REPORTS
  • 13.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: NEW TESTS LAUNCHED BY KEY PLAYERS
  • TABLE 2: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 3: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 4: NORTH AMERICA: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 5: EUROPE: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 6: ASIA PACIFIC: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 7: ROW: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 8: LATIN AMERICA: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 9: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 10: NORTH AMERICA: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 11: EUROPE: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 12: ASIA PACIFIC: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 13: ROW: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 14: LATIN AMERICA: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 15: MOLECULAR DIAGNOSTIC SERVICES & SOFTWARE MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 16: NORTH AMERICA: MOLECULAR DIAGNOSTIC SERVICES & SOFTWARE MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 17: EUROPE: MOLECULAR DIAGNOSTIC SERVICES & SOFTWARE MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 18: ASIA PACIFIC: MOLECULAR DIAGNOSTIC SERVICES & SOFTWARE MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 19: ROW: MOLECULAR DIAGNOSTIC SERVICES & SOFTWARE MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 20: LATIN AMERICA: MOLECULAR DIAGNOSTIC SERVICES & SOFTWARE MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 21: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 22: MOLECULAR DIAGNOSTICS MARKET FOR PCR, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 23: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR PCR, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 24: EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR PCR, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 25: ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR PCR, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 26: ROW: MOLECULAR DIAGNOSTICS MARKET FOR PCR, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 27: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR PCR, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 28: MOLECULAR DIAGNOSTICS MARKET FOR INAAT, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 29: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR INAAT, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 30: EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR INAAT, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 31: ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR INAAT, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 32: ROW: MOLECULAR DIAGNOSTICS MARKET FOR INAAT, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 33: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR INAAT, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 34: MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING AND NGS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 35: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING AND NGS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 36: EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING AND NGS, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 37: ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING AND NGS, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 38: ROW: MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING AND NGS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 39: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING AND NGS, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 40: MOLECULAR DIAGNOSTICS MARKET FOR IN SITU HYBRIDIZATION, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 41: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 42: EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 43: ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 44: ROW: MOLECULAR DIAGNOSTICS MARKET FOR IN SITU HYBRIDIZATION, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 45: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 46: MOLECULAR DIAGNOSTICS MARKET FOR DNA MICROARRAY, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 47: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR DNA MICROARRAY, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 48: EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR DNA MICROARRAY, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 49: ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR DNA MICROARRAY, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 50: ROW: MOLECULAR DIAGNOSTICS MARKET FOR DNA MICROARRAY, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 51: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR DNA MICROARRAY, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 52: MOLECULAR DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 53: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 54: EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 55: ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 56: ROW: MOLECULAR DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 57: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 58: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 59: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 60: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 61: EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 62: ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 63: ROW: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 64: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 65: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY DISEASE TYPE, 2016-2023 (USD MILLION)
  • TABLE 66: HEPATITIS DIAGNOSTICS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 67: HEPATITIS DIAGNOSTICS MARKET, BY REGION, 2016-2023 (MILLION ASSAYS)
  • TABLE 68: HIV DIAGNOSTICS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 69: HIV DIAGNOSTICS MARKET, BY REGION, 2016-2023 (MILLION ASSAYS)
  • TABLE 70: CT/NG DIAGNOSTICS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 71: CT/NG DIAGNOSTICS MARKET, BY REGION, 2016-2023 (MILLION ASSAYS)
  • TABLE 72: HAI DIAGNOSTICS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 73: HAI DIAGNOSTICS MARKET, BY REGION, 2016-2023 (MILLION ASSAYS)
  • TABLE 74: HPV DIAGNOSTICS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 75: HPV DIAGNOSTICS MARKET, BY REGION, 2016-2023 (MILLION ASSAYS)
  • TABLE 76: TB DIAGNOSTICS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 77: TB DIAGNOSTICS MARKET, BY REGION, 2016-2023 (MILLION ASSAYS)
  • TABLE 78: INFLUENZA DIAGNOSTICS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 79: INFLUENZA DIAGNOSTICS MARKET, BY REGION, 2016-2023 (MILLION ASSAYS)
  • TABLE 80: OTHER INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 81: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 82: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 83: EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 84: ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 85: ROW: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 86: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 87: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY, BY CANCER TYPE, 2016-2023 (USD MILLION)
  • TABLE 88: BREAST CANCER DIAGNOSTICS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 89: COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 90: LUNG CANCER DIAGNOSTICS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 91: PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 92: OTHER CANCER DIAGNOSTICS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 93: MOLECULAR DIAGNOSTICS MARKET FOR GENETIC TESTING, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 94: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR GENETIC TESTING, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 95: EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR GENETIC TESTING, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 96: ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR GENETIC TESTING, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 97: ROW: MOLECULAR DIAGNOSTICS MARKET FOR GENETIC TESTING, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 98: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR GENETIC TESTING, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 99: MOLECULAR DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 100: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 101: EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 102: ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 103: ROW: MOLECULAR DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 104: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 105: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 106: MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 107: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 108: EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 109: ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 110: ROW: MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 111: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 112: MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 113: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 114: EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 115: ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 116: ROW: MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 117: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 118: MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 119: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 120: EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 121: ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 122: ROW: MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 123: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 124: MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 125: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 126: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 127: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 128: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 129: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 130: US: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 131: US: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 132: US: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 133: US: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 134: CANADA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 135: CANADA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 136: CANADA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 137: CANADA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 138: EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 139: EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 140: EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 141: EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 142: EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 143: GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 144: GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 145: GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 146: GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 147: FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 148: FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 149: FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 150: FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 151: ITALY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 152: ITALY: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 153: ITALY: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 154: ITALY: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 155: SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 156: SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 157: SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 158: SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 159: UK: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2023 (USD MILLION)
  • TABLE 160: UK: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 161: UK: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 162: UK: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 163: ROE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 164: ROE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 165: ROE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 166: ROE: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 167: ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 168: ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 169: ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 170: ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 171: ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 172: JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 173: JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 174: JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 175: JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 176: CHINA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 177: CHINA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 178: CHINA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 179: CHINA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 180: AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 181: AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 182: AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 183: AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 184: INDIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 185: INDIA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 186: INDIA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 187: INDIA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 188: ROAPAC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 189: ROAPAC: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 190: ROAPAC: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 191: ROAPAC: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 192: ROW: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 193: ROW: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 194: ROW: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 195: ROW: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 196: ROW: MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 197: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 198: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 199: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 200: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 201: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 202: BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 203: BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 204: BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 205: BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 206: MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 207: MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 208: MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 209: MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 210: ROLA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 211: ROLA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 212: ROLA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 213: ROLA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 214: MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 215: MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 216: MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 217: MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 218: NEW PRODUCT LAUNCHES AND APPROVALS, 2016-2018
  • TABLE 219: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2016-2018
  • TABLE 220: ACQUISITIONS AND MERGERS 2016-2018
  • TABLE 221: EXPANSIONS, 2016-2018

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION
  • FIGURE 6: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT AND SERVICE, 2018 VS. 2023
  • FIGURE 7: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2018 VS. 2023
  • FIGURE 8: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2018 VS. 2023
  • FIGURE 9: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2018 VS. 2023
  • FIGURE 10: GEOGRAPHICAL SNAPSHOT OF THE MOLECULAR DIAGNOSTICS MARKET
  • FIGURE 11: INCREASING PREVALENCE OF INFECTIOUS DISEASES AND VARIOUS TYPES OF CANCERS - KEY DRIVERS FOR THE MARKET
  • FIGURE 12: PCR TECHNOLOGY TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2018
  • FIGURE 13: REAGENTS AND KITS TO DOMINATE THE MOLECULAR DIAGNOSTICS MARKET IN 2023
  • FIGURE 14: HOSPITAL AND ACADEMIC LABORATORIES TO ACCOUNT FOR THE LARGEST SHARE IN 2018
  • FIGURE 15: MOLECULAR DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 16: DNA SEQUENCING & NGS TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2018-2023)
  • FIGURE 17: GEOGRAPHICAL SNAPSHOT: ASIA PACIFIC TO BE THE FASTEST-GROWING REGIONAL SEGMENT IN THE MOLECULAR DIAGNOSTICS MARKET
  • FIGURE 18: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 19: ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 20: COMPANIES ADOPTED PRODUCT LAUNCHES AS THEIR KEY GROWTH STRATEGY OVER THE LAST THREE YEARS
  • FIGURE 21: GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2017
  • FIGURE 22: GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET RANKING, BY KEY PLAYER, 2017
  • FIGURE 23: GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR PCR, MARKET SHARE ANALYSIS, BY KEY PLAYER 2016
  • FIGURE 24: GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING AND NGS, MARKET SHARE ANALYSIS, BY KEY PLAYER, 2016
  • FIGURE 25: GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR ISH, BY KEY PLAYER, 2016
  • FIGURE 26: ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • FIGURE 27: AGILENT TECHNOLOGIES: COMPANY SNAPSHOT
  • FIGURE 28: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 29: BIOMERIEUX SA: COMPANY SNAPSHOT
  • FIGURE 30: DANAHER CORPORATION: COMPANY SNAPSHOT
  • FIGURE 31: DIASORIN: COMPANY SNAPSHOT 203  
  • FIGURE 32: GRIFOLS: COMPANY SNAPSHOT
  • FIGURE 33: HOLOGIC: COMPANY SNAPSHOT
  • FIGURE 34: ILLUMINA: COMPANY SNAPSHOT
  • FIGURE 35: QIAGEN: COMPANY SNAPSHOT (2017)
  • FIGURE 36: ROCHE DIAGNOSTICS: COMPANY SNAPSHOT
  • FIGURE 37: SIEMENS AG: COMPANY SNAPSHOT
  • FIGURE 38: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
Back to Top